Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-25

Clinical Trial Update: Comparison of the Effectiveness Level of Virtual Reality Exposure Therapy With Sertraline Treatment in Social Anxiety Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing virtual reality exposure therapy to sertraline for Social Anxiety Disorder; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Virtual Reality Exposure Therapy
  • Zoloft (sertraline)

Snippet

Sponsor: Emine Kanmaz | Conditions: Social Anxiety Disorder | Phase 4 | Status: RECRUITING